Your Full Service IVD MedTech CRO partner
MDx is your One Stop-Shop CRO for Medical Devices and IVDs
Working with you from the MedTech Patent to the Post-market
A MedTech CRO is a company that provides contract research organization services to aid medical device (MD) manufacturers. It covers the MD full life cycle. By offering expert consulting, quality assurance, medical device regulatory affairs, and clinical investigation expertise, it serves as the strong partner for the development of medical technologies.
An IVD CRO is a specialized contract research organization. It supports In Vitro Diagnostics (IVD) manufacturers and laboratories from patent to the post-market phase. An IVD CRO provides quality assurance, regulatory and clinical performance expertise to be the optimal partner for the development of in-vitro diagnostics technologies and in-house testing.
As a IVD MedTech CRO in Europe, MDx offers complete life-cycle expert support for your medical device and in-vitro diagnostics projects. The expert team designs an optimal plan for your CE Mark strategy to save time and resources in your medical device and diagnostics innovation pipeline. Covering the quality support in your QMS, the regulatory affairs consulting services for the development of Technical Documentation, and the medical writing for Clinical Evaluation and IVD Performance Evaluation and the Clinical Research Operations management under the EU MDR 2017/745 and EU IVDR 2017/746.
MDx CRO offers an integrated approach to managing the complete lifecycle of medical products. Specializing in MedTech CRO services, MDx provides expertise in research and development, clinical research, regulatory processes, and post-market activities. MDx simplifies the complex steps needed to bring a medical product to market, ensuring a streamlined, efficient process that meets industry standards. MDx offers the holistic solution in medical technology development.
Quality Assurance consulting services provide design, implementation, and management of Quality Management Systems following several standards for healthcare companies.
MedTech regulatory affairs consulting services cover the intended purpose definition of technical file development and other key points such as Risk Management and Clinical Evaluation.
The Clinical Research expert and strategist support provide the design and development of clinical investigations and performance studies. Medical Device Contract Research Organization services dedicated for Medical Devices, IVD and MDSW.
New EU regulations came into effect for MedTech and IVD companies. The EU Medical Device Regulation (MDR) 2017/745 and the EU In Vitro Diagnostic Regulation (IVDR) 2017/746 came into effect on May 26, 2021 and 2022, respectively. Namely, these new European regulations bring significant changes for MedTech IVD. Among the most relevant are expanded product coverage, alignment with European and international regulations, reclassification based on risk, stricter clinical evidence requirements, heightened scrutiny and involvement of Notified Bodies, increased focus on post-market surveillance, and updated quality management system (QMS) requirements.
MDx stands at the forefront of the MedTech and In Vitro Diagnostics industries, offering unparalleled expertise and innovative solutions. Our seasoned MDx experts guide clients through every step of product development, clinical studies, and regulatory compliance. With a commitment to quality and cutting-edge technologies, we transform challenges into strategic advantages, setting a high benchmark in MedTech CRO and IVD CRO services. Partner with us to navigate the complexities of the rapidly evolving MedTech landscape with confidence.
Over 17 years of experience
More than 100 clinical evaluations and studies
Worked with 500 IVD & medical devices
Specializing in ISO 13485 manufacturing and ISO 15189 laboratory Quality Management Systems, MDx serves as a valuable resource for organizations navigating the transition from IVDD to IVDR regulations. The company excels in carrying out comprehensive Performance Evaluations and in the design and implementation of Clinical Performance Studies, both observational and interventional. As a leading IVD CRO, the organization also offers specialized support for in-house IVDs and LDTs (Laboratory Developed Tests).
As a reputable MedTech CRO, MDx collaborates with regulatory consultants to provide comprehensive solutions for Medical Device CE Marking. Excelling in Quality Management System Implementation and adept at guiding transitions from MDD to MDR regulations, the company is a leader in the field. The Medtech CRO further distinguishes itself through its expertise in Clinical Evaluation, as well as in the design and execution of Clinical Investigations, PMCF studies, and Real-World Evidence/Real-World Data collection.
Collaboration with a healthcare software developer to get the CE Mark for Digital Health Solutions. Beginning with the implementation of dedicated Quality Management Systems for the design and development of SaMD (ISO 13485) and cybersecurity (ISO 27001), Data Science, Validation and Verification (ISO 62304), and Software Clinical Evaluations, which are supported by Clinical Evidences.
IVD CRO services for the development of a Clinical Performance Study for an IVD kit according ISO 20916:2019, GLP, GCP and EU IVDR 2017/746.
Development of the full MDR transition, including the Clinical Evaluation Plan, Systematic Literature Protocol and Report and the Clinical Evaluation Report according MEDDEV 2.7.1 rev 4, MDCG 2020-6 and EU Medical Device Regulation 2017/745.
Medical Device CRO services for the development of a Clinical Investigation for an MDSW according ISO 14155:2020, MDCG 2020-10 rev.1, MDCG 2021-6, MDCG 2021-8, MDCG 2021-20, MDCG 2021-28 and EU MDR Regulation 2017/745 in one Spanish site.
Local Medical Device CRO activities in one Spanish site from Ethics Committee submission to the Close Out according ISO 14155:2020 and EU MDR Regulation 2017/745.
Local MedTech CRO activities in five Spanish site from site management to the Close Out, according GCPs and ISO 14155:2020.
Quality Assurance Service support: Quality Management System ISO 13485 development and implementation.
Quality Assurance Service support: Quality Management System ISO 13485 development, implementation and maintenance.
Quality Assurance Service support: External Audits
MDx offers comprehensive consulting and project management services to help you achieve success in the competitive MedTech landscape.
MDx expertise in Medical Device Regulation, In-Vitro Diagnostic Regulation, ISO 14155, and ISO 20916 ensures that your projects are completed in compliance with industry standards.
Even when MDx adapts the project management for each MedTech CRO project, MDx provides some common steps and processes to facilitate transparency and control, using the following steps:
A strategist expert will collaborate with you to land the project defining activities and timelines. An easy-to-read budget will be released.
Both teams, manufacturer and MDx CRO, are introduced. The initial setup is established with the project's plan, milestones, and timelines.
MedTech CRO MDx team will provide periodic updates and ad-hoc meetings to cover the project´s needs.
The documentation will be shared with the manufacturer. The documentation is assessed by the manufacturer, and after that, the final version is released.
The last contact to evaluate the results of the project takes place with the team. It is the stage for exploring new projects.
FDA’s new LDT regulation underscores the vital role of IVD CROs in compliance and safety. Phased over four years without grandfathering, it highlights the necessity for IVD CROs’ regulatory expertise and their key role in aligning LDTs with stringent standards, marking a significant shift in the IVD landscape.
Learn more about the MedTech news from the latest IVD trends to the main figures in medical technology.
The EU Medical Device Regulation has introduced significant changes to the requirements for clinical evaluation reports of medical devices. This article provides a guidance on incorporating the relevant guidance from MDCG 2020-6, MDCG 2020-5, MDCG 2020-13, MEDDEV 2.7.1 rev4, and EU MDR Annex XIV into your CER.
The field of personalized medicine is experiencing notable progress as BSI and TÜV SÜD, two of the largest Notified Bodies in the European Union, have issued their first Companion Diagnostic (CDx) Certificates under the In Vitro Diagnostics Regulation (IVDR). This achievement carries substantial implications for IVD manufacturers and CROs.
Selecting an ISO 14155-compliant MedTech CRO under EU MDR ensures enhanced data reliability and patient safety. This compliance is key to successful clinical trials, aligning with MDR standards for quality and regulatory adherence, aiding manufacturers in the competitive MedTech field.
We are delighted to meet with you for a free initial consultation to provide expert support and learn more about your project, medical device, software as a medical device or IVD under IVDR and MDR regulations.
Please provide a brief description of your project, and we will work to establish the next steps in your regulatory, clinical research (clinical investigations and clinical performance studies) and quality strategic planning or contact us at contact@mdxcro.com.
Contact us today to learn more about our MDx services and how we can help you achieve your goals in the fast-evolving of the medical technologies as your MedTech CRO and IVD CRO partner.
MED IVD HEALTHTECH S.L ha sido beneficiaria de la subvención de contratos de trabajo de la Comunidad de Madrid, cofinanciado por el Fondo Social Europeo dentro de la Ayuda a la Recuperación para la Cohesión y los Territorios de Europa (REACT-UE), a través del Programa Operativo Regional FSE, en el marco del Programa Impulso a la Contratación Estable de Jóvenes para la Recuperación Económica, gestionado por la Dirección General del Servicio Público de empleo de la Consejería de Economía, hacienda y empleo de la Comunidad de Madrid.
© 2024 Copyright MDx | MedTech IVD CRO.
Dark mode is activated. Turn off